MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) Sees Large Decrease in Short Interest

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGYGet Rating) was the target of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 1,700 shares, a drop of 61.4% from the April 15th total of 4,400 shares. Based on an average daily volume of 122,400 shares, the days-to-cover ratio is presently 0.0 days.

Shares of OTCMKTS:MKKGY traded down $0.11 during midday trading on Friday, hitting $33.20. The company’s stock had a trading volume of 127,916 shares, compared to its average volume of 75,063. The business’s 50 day simple moving average is $38.92 and its 200 day simple moving average is $43.72. MERCK Kommanditgesellschaft auf Aktien has a 12-month low of $33.00 and a 12-month high of $52.29.

Several analysts have recently issued reports on the stock. Morgan Stanley lifted their target price on shares of MERCK Kommanditgesellschaft auf Aktien from €220.00 ($231.58) to €225.00 ($236.84) and gave the company an “equal weight” rating in a research report on Friday, April 29th. Credit Suisse Group dropped their target price on shares of MERCK Kommanditgesellschaft auf Aktien from €208.00 ($218.95) to €200.00 ($210.53) and set an “outperform” rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, MERCK Kommanditgesellschaft auf Aktien currently has an average rating of “Hold” and a consensus target price of $231.67.

About MERCK Kommanditgesellschaft auf Aktien (Get Rating)

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology.

Featured Stories

Receive News & Ratings for MERCK Kommanditgesellschaft auf Aktien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MERCK Kommanditgesellschaft auf Aktien and related companies with MarketBeat.com's FREE daily email newsletter.